Santé log21m
KFSHRC Pioneers Cancer Treatment with Breakthrough Therapies and Exceptional Outcomes
KFSHRC is also advancing genomic medicine with CRISPR-Cas9 gene editing and personalized cancer therapies, including the ...
Santé log20m
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that the staff of ...
Santé log22m
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that it has received a formal notice from ...
Santé log25m
Roche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study
The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic macular edema (DME) treated with Vabysmo who identify as African American, ...
Santé log18m
Le KFSHRC impose son leadership en matière de veille dans les soins de santé pour le diagnostic et les soins aux patients
Le KFSHRC poursuit le développement de ses capacités en matière d’IA avec JuhAIna, un système d’IA générative conçu pour ...